These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 24919928)

  • 1. The association of -330 interleukin-2 gene polymorphism and HLA-DR15 allele in Iranian patients with multiple sclerosis.
    Sayad A
    Int J Immunogenet; 2014 Aug; 41(4):330-4. PubMed ID: 24919928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran.
    Abolfazli R; Samadzadeh S; Sabokbar T; Siroos B; Armaki SA; Aslanbeiki B; Ghelman M; Taheri T; Shakoori A
    J Neurol Sci; 2014 Oct; 345(1-2):92-6. PubMed ID: 25064442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of HLA-DRB1*1501 allele and TNF-alpha -308 G/A single nucleotide polymorphism in the susceptibility to multiple sclerosis.
    Shahbazi M; Roshandel D; Omidnyia E; Rshaidbaghan A
    Clin Immunol; 2011 Jun; 139(3):277-81. PubMed ID: 21396892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High frequency of the IL-2 -330 T/HLA-DRB1*1501 haplotype in patients with multiple sclerosis.
    Shahbazi M; Roshandel D; Ebadi H; Fathi D; Zamani M; Boghaee M; Mohammadhoseeeni M; Rshaidbaghan A; Bakhshandeh A; Shahbazi S
    Clin Immunol; 2010 Oct; 137(1):134-8. PubMed ID: 20594918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of Myelin Basic Protein Gene Polymorphisms with HLA-DRB1*1501 in Iranian Patients with Multiple Sclerosis.
    Nejati P; Attar M; Rahimian M; Fathi D; Shahbazi M
    Iran J Immunol; 2017 Sep; 14(3):231-239. PubMed ID: 28919586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are IL2 promoter polymorphisms associated with MS in Iranian patients? - We do not know.
    Jabalameli MR; Zahednasab H
    Int J Immunogenet; 2014 Dec; 41(6):528-9. PubMed ID: 25399512
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic factors and multiple sclerosis in the Moroccan population: a role for HLA class II.
    Ouadghiri S; El Alaoui Toussi K; Brick C; Ait Benhaddou EH; Benseffaj N; Benomar A; El Yahyaoui M; Essakalli M
    Pathol Biol (Paris); 2013 Dec; 61(6):259-63. PubMed ID: 23849771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The +190 G/A (rs1799864) polymorphism in the C-C chemokine receptor 2 (CCR2) gene is associated with susceptibility to multiple sclerosis in HLA-DRB1*15:01-negative individuals.
    Javor J; Párnická Z; Michalik J; Čopíková-Cudráková D; Shawkatová I; Ďurmanová V; Gmitterová K; Klímová E; Bucová M; Buc M
    J Neurol Sci; 2015 Feb; 349(1-2):138-42. PubMed ID: 25604634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E polymorphisms status in Iranian patients with multiple sclerosis.
    Rafiei M; Zarif Yeganeh M; Sheikholeslami S; Gozalpour E; Ghaffarpour M; Hedayati M
    J Neurol Sci; 2012 Sep; 320(1-2):22-5. PubMed ID: 22698480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of interleukin-10 gene promoter polymorphisms with HLA-DRB1*15 allele is associated with multiple sclerosis.
    Shahbazi M; Abadi JSA; Roshandel D; Koochaki M; Amiri H; Kohansal R; Baghbanian SM; Zamani M
    Indian J Med Res; 2017 Jun; 145(6):746-752. PubMed ID: 29067976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
    Silva AM; Pereira C; Bettencourt A; Carvalho C; Couto AR; Leite MI; Marta M; Freijo M; Costa PP; Mendonça D; Monteiro L; Armas JB; Martins B
    J Neurol Sci; 2007 Jul; 258(1-2):69-74. PubMed ID: 17412364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The study on relation of HLA-DRB1 gene polymorphism to Keshan disease and its association and linkage in the core families].
    Wei J; Niu XL; Dong X; Wang YP; Zhu JH
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):91-3. PubMed ID: 17285554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
    Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study.
    Wu JS; James I; Wei Qiu ; Castley A; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG
    Mult Scler; 2010 May; 16(5):526-32. PubMed ID: 20207784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of -475 and -631 interleukin-2 gene polymorphism with multiple sclerosis in Iranian patients.
    Sayad A; Allameh A; Sayad A; Noruzinia M; Akbari MT; Sarzaeem A; Akbar A; Haji Hoseini R
    Cell J; 2013; 15(2):124-9. PubMed ID: 23862113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association of HLA-DRB1 and -DPB1 allele polymorphism with multiple sclerosis in Chinese Han population from Southern areas].
    Wu XM; Zhang KN; Wang CD; Xiong YQ; Liu Z; Qu XH; Xie XF
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2741-4. PubMed ID: 18167262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of CD1A +622 T/C, +737 G/C and CD1E +6129 A/G genes polymorphisms with multiple sclerosis.
    Jamshidian A; Nikseresht AR; Vessal M; Kamali-Sarvestani E
    Immunol Invest; 2010; 39(8):874-89. PubMed ID: 20954848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of HLA class II alleles and CTLA-4 polymorphism with type 1 diabetes.
    Ei Wafai RJ; Chmaisse HN; Makki RF; Fakhoury H
    Saudi J Kidney Dis Transpl; 2011 Mar; 22(2):273-81. PubMed ID: 21422625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A NOTCH4 missense mutation confers resistance to multiple sclerosis in Japanese.
    Huang J; Yoshimura S; Isobe N; Matsushita T; Yonekawa T; Sato S; Yamasaki R; Kira J;
    Mult Scler; 2013 Nov; 19(13):1696-703. PubMed ID: 23549433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the multiple sclerosis associated -330 promoter polymorphism in IL2 allelic expression.
    Matesanz F; Fedetz M; Leyva L; Delgado C; Fernández O; Alcina A
    J Neuroimmunol; 2004 Mar; 148(1-2):212-7. PubMed ID: 14975604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.